Status:
UNKNOWN
Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP
Lead Sponsor:
Hanyang University
Conditions:
Biliary Tract Diseases
Pancreatic Diseases
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The aim of this study is to compare sedation efficiency, safety and satisfaction by both endoscopist, assistants, and the patients between continuous infusion and intermittent bolus injection of propo...
Detailed Description
The patients undergone ERCP were randomly assigned to either continuous infusion of propofol (continuous group) or midazolam plus intermittent bolus injection of propofol (intermittent group) for deep...
Eligibility Criteria
Inclusion
- Patients undergone ERCP for biliary and pancreatic diseases
Exclusion
- Comorbid conditions of ASA class 4-5
- Age under 18 years or over 90 years
- Pregnancy
- Past medication history of benzodiazepine or narcotics
- Known allergy to midazolam or propofol
- hypotension (systolic blood pressure \<90 mmHg), hypoxemia (SaO2 \<90%), or bradycardia (50/min) at baseline measurements
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2014
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01900938
Start Date
September 1 2013
End Date
May 1 2014
Last Update
July 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanyang University Guri Hospital
Guri-si, Gyeonggi-do, South Korea, 471-701